drugset / Trial / NCT01906801
Clinical Efficacy of Glucosamine Plus Diacerein Versus Mono-therapy of Glucosamine
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare pain scores, WOMAC total and subscores, actual and change of joint space width and the rate of gastrointestinal side effects at 4, 8, 12, and 24 weeks between dual-therapy of diacerein and glucosamine versus a mono-therapy of glucosamine in OA patients
Timeline
- Start
- 2013-07
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diacerein | Small molecule | 50 mg | Oral |
| Subject | Glucosamine | Small molecule | 1500 mg | Oral |